---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-115106"
form_type: "8-K"
ticker: "CCEL"
cik: "0000862692"
company_name: "CRYO CELL INTERNATIONAL INC"
filed_at: "2024-10-17T23:59:59+00:00"
generated_at: "2026-05-30T13:31:03.990763+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Cryo-Cell Q3 revenue $8.07M, net income $1.05M; strategic review ongoing, spinoff on hold

## Summary
- Revenue $8.07M vs $7.87M YoY; net income $1.05M ($0.13/diluted) vs $0.68M ($0.08).
- Gains on marketable securities $522k vs $93k YoY, boosting earnings.
- Company exploring strategic alternatives to maximize shareholder value; process ongoing.
- Spinoff of Celle Corp on hold due to arbitration demand with Duke University (see Form 10-Q).
- Board considering instituting regular quarterly dividend; no decision yet.

## SEC filing metadata
- accession: 0000950170-24-115106
- form_type: 8-K
- ticker: CCEL
- cik: 0000862692
- company_name: CRYO CELL INTERNATIONAL INC
- filed_at: 2024-10-17T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/862692/000095017024115106/0000950170-24-115106-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/862692/000095017024115106/ccel-20241015.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-115106
- JSON: https://secwatch.observer/filing/0000950170-24-115106.json
- Plain text: https://secwatch.observer/filing/0000950170-24-115106.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.